Why has tuberculosis, a treatable and curable disease, proved so resistant to elimination?
Why, in fact, are the numbers of cases, particularly drug-resistant cases, increasing? Almost …

The approximately 1.2 million inmates in US correctional institutions have a high prevalence
of communicable diseases, such as human immunodeficiency virus (HIV) infection …

Abstract During 1993-2003, incidence of tuberculosis (TB) in the United States decreased
44% and is now occurring at a historic low level (14,874 cases in 2003). The Advisory …

Three epidemiologically linked multi drug-resistant (MDR) tuberculosis (TB) outbreaks in
1990–1991 involving New York State (NYS) inmates suggested MDR-TB was widespread in …

Poverty drives tuberculosis (TB) rates but the approach to TB control has been
disproportionately biomedical. In 2015, the World Health Organization's End TB Strategy …

Objectives: We sought to describe disparities and trends in tuberculosis (TB) risk factors and
treatment outcomes between correctional inmate and noninmate populations. Methods: We …

Isoniazid chemoprophylaxis has long been known to be a highly effective means of
preventing silent tuberculous infections from spreading to active disease. There has been …

Background Adherence to treatment of persons with latent tuberculosis infection after
release from jail has been poor. Methods A randomized controlled trial was conducted at the …

Background Isoniazide preventive therapy (IPT) is given to individuals with latent infection of
tuberculosis (TB) to prevent the progression to active disease. One of the primary reasons …

The rise in tuberculosis (TB) has disproportionately affected specific populations.
Historically, many patients with TB became iatrogenic opiate addicts through therapeutic use …